Survival from breast cancer in women with a BRCA2 mutation by treatment-Reference-Cited by-同舟云学术

Survival from breast cancer in women with a BRCA2 mutation by treatment

Published:2021-02-18 Issue:9 Volume:124 Page:1524-1532
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Evans D. Gareth, ,Phillips Kelly-Anne^ORCID,Milne Roger L.,Fruscio Robert,Cybulski Cezary,Gronwald Jacek,Lubinski Jan,Huzarski Tomasz,Hyder Zerin,Forde Claire,Metcalfe Kelly,Senter Leigha,Weitzel Jeffrey,Tung Nadine,Zakalik Dana,Ekholm Maria,Sun Ping,Narod Steven A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-020-01164-1.pdf

Reference17 articles.

1. Byrski, T., Gronwald, J., Huzarski, T., Grzybowska, E., Budryk, M., Stawicka, M. et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J. Clin. Oncol. 28, 375–379 (2010).

2. Narod, S. A., Huzarski, T., Gronwald, J., Byrski, T., Marczyk, E., Cybulski, C. et al. Predictors of survival for breast cancer patients with a BRCA1 mutation. Breast Cancer Res. Treat. 168, 513–521 (2018).

3. Metcalfe, K., Lynch, H. T., Foulkes, W. D., Tung, N., Kim-Sing, C., Olopade, O. I. et al. Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. JAMA Oncol. 1, 306–313 (2015).

4. Metcalfe, K., Gershman, S., Ghadirian, P., Lynch, H. T., Snyder, C., Tung, N. et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348, g226 (2014).

5. Jayasekara, H., MacInnis, R. J., Chamberlain, J. A., Dite, G. S., Leoce, N. M., Dowty, J. G. et al. Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis. Int. J. Cancer 145, 3207–3217 (2019).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer and Pregnancy in Young BRCA Carriers;JAMA;2024-04-09

2. ER-positive and BRCA2-mutated breast cancer: a literature review;European Journal of Medical Research;2024-01-06

3. The impact of the HER2-low status on conditional survival in patients with breast cancer;Therapeutic Advances in Medical Oncology;2024-01

4. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis;Therapeutic Advances in Medical Oncology;2024-01

5. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients;npj Breast Cancer;2023-11-30